SCHEMBL5640741

SCHEMBL5640741

c1ccc(CN2CCCC(n3ncc4cc(Oc5ccc6c(cnn6C6CCCN(Cc7ccccc7)C6)c5)ccc43)C2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 7/20 0.51
ROCK2 O75116 6/20 0.51
CCR2 P41597 3/20 0.50
KCNH2 Q12809 1/20 0.46
JAK2 O60674 3/20 0.45
JAK1 P23458 3/20 0.45
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
ALDH1A1 P00352 1/20 0.44
TYK2 P29597 2/20 0.43
JAK3 P52333 2/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
KDM4E B2RXH2 1/20 0.42
TMEM97 Q5BJF2 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
CHRM3 P20309 1/20 0.41
KAT2B Q92831 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5640699 0.91 ROCK2 (0.47) ROCK1ROCK2CCR2MEN1KMT2A
SCHEMBL5639528 0.90 ROCK2 (0.46) ROCK1ROCK2CCR2ALDH1A1
SCHEMBL5642918 0.89 ROCK1 (0.44) ROCK1ROCK2CCR2KDM4EKAT2B
SCHEMBL5639768 0.88 DRD4 (0.52) ROCK1ROCK2CCR2ALDH1A1KMT2A
SCHEMBL5641849 0.88 ROCK1 (0.46) ROCK1ROCK2CCR2ALDH1A1KDM4E
SCHEMBL5639886 0.79 DRD4 (0.56) ROCK1ROCK2CCR2ALDH1A1KDM4E
SCHEMBL5639738 0.78 OPRM1 (0.43) ROCK1ROCK2CCR2ALDH1A1TMEM97
SCHEMBL4415857 0.77 CYP1A2 (0.46) ROCK1ROCK2CCR2JAK2JAK1
SCHEMBL5640351 0.77 ALDH1A1 (0.47) KCNH2ALDH1A1KMT2ATMEM97SIGMAR1
SCHEMBL5641132 0.75 OPRM1 (0.53) ROCK1ROCK2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7217722-B2 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2007-05-15 US disclosed
US-20040102437-A1 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same KYOWA HAKKO KIRIN CO., LTD. (JP) 2004-05-27 US disclosed
EP-1256574-A1 NITROGEN-CONTAINING COMPOUNDS HAVING KINASE INHIBITORY ACTIVITY AND DRUGS CONTAINING THE SAME KIRIN BEER KABUSHIKI KAISHA (JP) 2002-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102437-A1 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same TNK2, ROCK1, ROCK2 ROCK1 2/4885ROCK2 3/4885CCR2 3344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.